Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
n. Zounemat Kermani (London, United Kingdom), S. Pavlidis (London, United Kingdom), J. Riley (London, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), Y. Guo (London, United Kingdom). Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED. 2347

Member's Comments

No comment yet.

Related content which might interest you: COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021 Year: 2022 Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes Source: Eur Respir J 2014; 44: 985-993 Year: 2014 Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Proteomic derived biomarkers for COPD are present in induced sputum Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005 The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019 Year: 2020 A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Sputum transcriptomic analysis of air pollutant signatures: link to asthma severity and phenotype Source: Virtual Congress 2021 – Environment and air pollution Year: 2021 Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes Source: Eur Respir J 2015; 46: 688-696 Year: 2015 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 Change of biochemical parameters of sputum in patients with different types of COPD exaserbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Repeatability of inflammatory analysis in induced sputum samples in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004 Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Blood inflammatory phenotypes of asthma in the Constances cohort Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Detailed physiological profiling of patients for a study investigating the airway microbiome Source: International Congress 2018 – Innovations in equipment and their application Year: 2018